MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/20420188251343140

Медицинская библиотека · Therapeutic advances in endocrinology and metabolism · 2025

Novel therapeutic targets for metabolism-related diseases: proteomic Mendelian randomization and colocalization analyses.

Zhang Yue-Yang, Wang Bin-Lu, Chen Bing-Xue, Wan Qin

СтатьяПеревод в очереди

Аннотация

BACKGROUND

In recent years, driven by the rapid advancement of proteomics research, numerous scholars have investigated the intricate associations between plasma proteins and various diseases. Thus, this study aimed to identify novel therapeutic targets for preventing and treating metabolic-related diseases through Mendelian randomization (MR).

METHODS

This study primarily utilized the MR method, leveraging genetic data from multiple large-scale publicly available genome-wide association studies. We employed two-sample MR within this framework to assess the associations between 1001 plasma proteins and 5 metabolism-related diseases. Finally, we strengthen the robustness and reliability of the MR results by conducting a series of sensitivity analyses, including bidirectional MR, colocalization analysis, Cochran's Q test, and the MR-Egger intercept test.

RESULTS

The results from the inverse variance weighted method revealed that, following false discovery rate correction, many plasma proteins are significantly associated with metabolic-related diseases. Genetically predicted risks vary across diseases: for coronary artery disease, from 0.82 FGR proto-oncogene, Src family tyrosine kinase (FGR) to 1.13 (interleukin-6); for obesity, from 0.992 (POLR2F) to 1.005 (PRKAB1); for osteoporosis, from 0.998 (AIF1) to 1.001 (CLC); for stroke, from 0.71 (TNFRSF1A) to 1.47 (TGM2); and for type 2 diabetes, from 0.79 (KRT18) to 1.47 (RAB37).

CONCLUSION

Our findings reveal numerous plasma proteins linked to metabolic-related diseases. These findings offer fresh insights into the etiology, diagnostics, and treatment of these conditions.

Для цитирования: Zhang Yue-Yang, Wang Bin-Lu, Chen Bing-Xue, Wan Qin. Novel therapeutic targets for metabolism-related diseases: proteomic Mendelian randomization and colocalization analyses.. Therapeutic advances in endocrinology and metabolism. 2025. DOI: 10.1177/20420188251343140.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.